Skip to content
AnalystLens

Veeva Systems 8-K Report, Financial Results (Aug 27, 2025)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed August 27, 2025
Period End
August 27, 2025
Security
VEEV
In the record · 2016–202610-K1110-Q328-K94

VEEV filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 94 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Nov ’19Nov ’19
  2. Leadership change8-K · Aug ’22Aug ’22
  3. Leadership change8-K · Aug ’26Aug ’26

01—Abstract

Summary

Summary of the 8-K filed August 27, 2025. Cited figures are marked; the original filing is the authoritative source.

Veeva Systems Inc. reported fiscal 2026 second-quarter results for the period ended July 31, 2025, through a press release furnished as Exhibit 99.1 to this Form 8-K.

Total revenues were $789.1 milliona, up 17% from $676.2 million a year earlier, and subscription services revenues were $659.2 million, up 17% from $561.3 million. GAAP operating income was $195.9 million (up 18% from $166.5 million), and GAAP net income was $200.3 million, or $1.19 per fully diluted share, compared with $1.04 a year earlier. Non-GAAP operating income rose 26% to $352.6 million, and non-GAAP fully diluted net income per share was $1.99, compared with $1.62.

The company stated that all metrics outperformed its guidance. Second-quarter GAAP results included $30.6 millionb of litigation settlement-related charges, which the company excludes from non-GAAP measures. Management highlighted progress on Veeva AI, with the first AI agents planned for release in December for CRM and commercial content, and Vault CRM, which now has more than 100 customers live and a seventh top 20 biopharma commitment in August.

The company also announced a long-term global partnership with IQVIA and the complete resolution of all pending legal disputes between the two companies in August. For the fiscal third quarter ending October 31, 2025, Veeva guided to total revenues of $790 to $793 millionc and non-GAAP operating income of $348 to $350 million.

It updated fiscal 2026 guidance to total revenues of $3,134 to $3,140 milliond, non-GAAP operating income of about $1,388 million, and non-GAAP fully diluted net income per share of approximately $7.78. The company stated it cannot provide GAAP targets for operating income or per-share net income because of items, such as stock-based compensation, that are difficult to predict.

02—Key points

Key Highlights

  1. Q2 fiscal 2026 total revenues were $789.1 million, up 17% year over year; subscription services revenues were $659.2 million, also up 17%.
  2. GAAP operating income was $195.9 million (up 18%), and non-GAAP operating income was $352.6 million (up 26%) versus $279.8 million a year earlier.
  3. GAAP net income was $200.3 million, or $1.19 per diluted share, versus $1.04 a year earlier; non-GAAP net income was $333.4 million, or $1.99 per diluted share, versus $1.62.
  4. Q2 GAAP results included $30.6 million of litigation settlement-related charges, excluded from non-GAAP results.
  5. Fiscal Q3 2025 guidance: total revenues of $790 to $793 million, non-GAAP operating income of $348 to $350 million, and non-GAAP diluted EPS of $1.94 to $1.95.
  6. Updated fiscal 2026 guidance: total revenues of $3,134 to $3,140 million, non-GAAP operating income of about $1,388 million, and non-GAAP diluted EPS of approximately $7.78.
  7. Veeva and IQVIA announced a long-term global partnership and the complete resolution of all pending legal disputes in August; Veeva AI agents are planned for release starting in December.

03—Questions

Frequently Asked Questions

  1. How did Veeva perform in its fiscal 2026 second quarter?

    Total revenues were $789.1 million, up 17% year over year, and subscription services revenues were $659.2 million, also up 17%. GAAP operating income was $195.9 million and GAAP net income was $200.3 million, or $1.19 per diluted share. Non-GAAP operating income was $352.6 million and non-GAAP diluted EPS was $1.99. Management said all metrics outperformed its guidance.

  2. What is Veeva's outlook for the third quarter and full fiscal year?

    For the quarter ending October 31, 2025, Veeva expects total revenues of $790 to $793 million, non-GAAP operating income of $348 to $350 million, and non-GAAP diluted EPS of $1.94 to $1.95. For the fiscal year ending January 31, 2026, it updated guidance to total revenues of $3,134 to $3,140 million, non-GAAP operating income of about $1,388 million, and non-GAAP diluted EPS of approximately $7.78.

  3. Why does Veeva not provide GAAP guidance for operating income and EPS?

    The company states it is not able to provide GAAP targets for operating income and fully diluted net income per share because of the difficulty of estimating items it excludes from non-GAAP results, such as stock-based compensation expense. It notes the effect of these excluded items may be significant.

  4. What legal developments were disclosed?

    Veeva and IQVIA announced a long-term global partnership and the complete resolution of all pending legal disputes in August. Veeva also recorded $30.6 million of litigation settlement-related charges in the quarter, which it excludes from non-GAAP results.

  5. What product developments did management highlight?

    Management highlighted Veeva AI, including agentic AI in the Vault Platform and industry-specific application agents, with the first agents planned for December for CRM and commercial content. Vault CRM now has more than 100 customers live, and a seventh top 20 biopharma committed to it in August. Patient CRM was also released in August.

04—Continue

← View all 8-K filings